The Beauty Health Company (SKIN) Misses Q2 EPS by 2c, beats revenue, offers guidance

The Beauty Health Company (NASDAQ: SKIN) reported Q2 EPS of $0.03, $0.02 worse than the analyst estimate of $0.05. Revenue for the quarter came in at $117.5 million versus the consensus estimate of $114.89 million.

GUIDANCE:

The Beauty Health Company sees Q3 2023 revenue of $460-480 million.

For earnings history and earnings-related data on The Beauty Health Company (SKIN) click here.

You May Also Be Interested In

• Lennar Corp. (LEN) Misses Q3 EPS by 10c
• CoreWeave signs new compute contracts at $40M per megawatt pricing
• Baird Reiterates Outperform Rating on GE Vernova (GEV)